Landmark biodiversity deal signed in Japan
Biotech firms will have to get consent from indigenous communities to exploit genetic resources under a landmark agreement last week in Nagoya, Japan
The protocol adopted at the UN Convention on Biological Diversity (CBD) also requires profits from any commercial products to be shared “fairly and equitably”.
Although there is much dispute over the meaning of the Nagoya protocol’s diplomatic language, its impact...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.